These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15662974)

  • 21. O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation.
    Rolhion C; Penault-Llorca F; Kemeny JL; Kwiatkowski F; Lemaire JJ; Chollet P; Finat-Duclos F; Verrelle P
    Int J Cancer; 1999 Aug; 84(4):416-20. PubMed ID: 10404096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.
    Lee D; Suh YL; Park TI; Do IG; Seol HJ; Nam DH; Kim ST
    J Surg Oncol; 2013 May; 107(6):646-52. PubMed ID: 22926763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.
    Jaeckle KA; Eyre HJ; Townsend JJ; Schulman S; Knudson HM; Belanich M; Yarosh DB; Bearman SI; Giroux DJ; Schold SC
    J Clin Oncol; 1998 Oct; 16(10):3310-5. PubMed ID: 9779706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.
    Sonoda Y; Yokosawa M; Saito R; Kanamori M; Yamashita Y; Kumabe T; Watanabe M; Tominaga T
    Int J Clin Oncol; 2010 Aug; 15(4):352-8. PubMed ID: 20232102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas.
    Tanaka S; Kobayashi I; Utsuki S; Oka H; Fujii K; Watanabe T; Nagashima T; Hori T
    Int J Cancer; 2003 Jan; 103(1):67-72. PubMed ID: 12455055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.
    Mineura K; Yanagisawa T; Watanabe K; Kowada M; Yasui N
    Int J Cancer; 1996 Oct; 69(5):420-5. PubMed ID: 8900378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
    Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
    Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
    J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
    Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
    Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
    Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
    Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients.
    Chen ZP; Yarosh D; Garcia Y; Tampieri D; Mohr G; Malapetsa A; Langleben A; Panasci LC
    Can J Neurol Sci; 1999 May; 26(2):104-9. PubMed ID: 10352868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.
    Miyazaki M; Nishihara H; Terasaka S; Kobayashi H; Yamaguchi S; Ito T; Kamoshima Y; Fujimoto S; Kaneko S; Katoh M; Ishii N; Mohri H; Tanino M; Kimura T; Tanaka S
    Neuropathology; 2014 Jun; 34(3):268-76. PubMed ID: 24397721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
    Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
    Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
    Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
    Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characteristics of pediatric non-ependymal, non‑pilocytic gliomas associated with resistance to temozolomide.
    Ezaki T; Sasaki H; Hirose Y; Miwa T; Yoshida K; Kawase T
    Mol Med Rep; 2011; 4(6):1101-5. PubMed ID: 21874248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics.
    Silber JR; Bobola MS; Ghatan S; Blank A; Kolstoe DD; Berger MS
    Cancer Res; 1998 Mar; 58(5):1068-73. PubMed ID: 9500473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas.
    Ueda S; Mineta T; Nakahara Y; Okamoto H; Shiraishi T; Tabuchi K
    J Neurosurg; 2004 Oct; 101(4):659-63. PubMed ID: 15481722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
    Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
    Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.
    Watanabe R; Nakasu Y; Tashiro H; Mitsuya K; Ito I; Nakasu S; Nakajima T
    Brain Tumor Pathol; 2011 Apr; 28(2):127-35. PubMed ID: 21331613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.